Oqsilni sintez qilish uchun ishlatiladigan aminokislotaning aralashmalari
Mahsulot tafsilotlari
| NO | Mahsulotlar | Cas yo'q | Asosiy sifat ko'rsatkichlari | |||
| Poklik | Maks.
|
| Namlik | |||
| 1 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | Fmok-d-ala-d-ala-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | Fmok-b-ala-d-ala-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | FMROC-Arg (PBF) -Barg (PBF) -Ha | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | FMROC-ALA-HOMOARG (PBF) -X | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | FMROC-AKN (TRT) -ASN (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | Fmok-as (otbu) - (otbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | Fmok-b-Ala-as (otbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | FMOC-CYS (TRT) -cys (TRT) -Ha | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | FMOC-ALA-CYS (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | FMOC-CYS (ACM) -cys (ACM) -Ha | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | FMROC-GLN (TRT) -Gnn (TRT) -Hox | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | FMROC-GLU (OTBU) -Gu (Otbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | FMOC-ALA-GLU (OTBU) -O.H2O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | FMOC-ALA-GLI-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | FMOC - uning (TRT) (TRT) -Ha | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | FMOC-ALA - Uning (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | FMOC-ILE-OY - Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | FMOC-ALA-ILE - Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | Fmok-leu-le-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | FMOC-ALA-LEU-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | Fmok-d-leu-d-leu oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | FMOC-ALA-D-LEU-OY | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | Fmok-lys (botqoq) - (BOC) -Hoh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | FMOC-ALA-LOYS (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | FMOC-LYS (ALCS) - by (alok) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | FMOC-ALA-LOYS (ALOC) -Ha | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | FMOC-Oh-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | FMOC-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | FMOC-OR (BOC) -Haych (Bok) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | FMOC-ALA-OR (BOC) -Hoh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | Fmok-phe-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | FMOC-ALA-PHE-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | FMROG D-Phe-D-Phe-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | FMOC-ALA-D-Phe-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | Fmok-pro-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | Fmok-ala-pro-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | FMOC-SER (TBU) - (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | FMOC-ALA-SER (TBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | FMOC-SER (TRT) - (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | FMOC-ALA-SER (TRT) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | FMROC-CR (TBU) -Hht (Tbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | FMOC-ALAA - (TBU) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | Fmok-trp (BOC) -TRP (BOC) -Hoh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | FMOC-ALA-TRP (BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | FMROC-D-TRRP (BOC) -D-TRP (BOC) -Hoh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 |
| NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | FMOC-ALA-TIR (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | FMROD D-Tir (ET) -D-Tir (ET) -Ha | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | FMOC-ALA-D-Tir (ET) -Ha | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | FMOC-Tir (Me) -Niz (Me) -Ha | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | FMOC-ALA-Tir (Me) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | FMR-Val-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | FMOC-ALA-VA-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | FMOC-D-CIT-D-CIT-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | FMOC-ALA-D-CIT-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | FMOC-ALA-DAB - Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | FMOC- (3- (2-noptil) -d-ala) 2 - oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | FMOC-ALA-3- (2-NAPTILLI) - Ali-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | FMOC- (3- (3-piridinil) -d-ala) 2 - oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | FMROC-ALA-3- (3-piridinil) - ala-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | FMOC- (4-Xloro-D-Phe) 2-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | FMOC-ALA-4-Xloro-D-Phe-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | FMOC- (D-4af (TBUCBM)) 2 - oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | FMOC-ALA-D-4afasi (Tbucmm) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | FMROC-APH (L-HOR) -afa (L-HOR) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | FMOC-ALA-APH (L-HOR) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | FMOC-LYS (IPR, BOC) - (IPR, BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | FMOC-ALA-LYS (IPR, BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | FMOC-ALA-AEEA-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | FMOC-AIB-AIB-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | FMOC-ALA-AIB-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | FMOC-AR-O oh | 91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | H arg (pbf) -oh | 200115-86-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | Fmok-d-arg-oh | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | HD-Arg (PBF) -Ha | 200116-81-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | Fmok-homoarg-oh.hcl | 208174-14-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | H-Gomabarg (PBF) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | Fmok-d-gomolar | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | HD-Gomolarg (PBF) -X | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | FMOC-ASN-OY | 71989-16-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | H-Ann (TRT) -Ha | 132388-58-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | Fmok-Oh | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | H-as (otbu) -oh | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | Fmok-cys - oh | 135248-89-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | H-cys (TRT) -Ha | 2799/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | H-cys (ACM) -O.Hcl | 28798-28-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | Fmok-gln-oh | 71989-20-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | H-GLN (TRT) -Hox | 102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | Fmok-glu-oh | 121343-82-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | H-GLU (OTBU) -O.H2O | 2419-56-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 100 | FMOC-Oh | 116611-64-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 101 | H-uni (TRT) -Ha | 35146-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 102 | BOC-Oh | 17791-52-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 103 | Fmok-lys-oh | 105047-45-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 104 | H-LOYS (BOC) -OH | 2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 105 | H-Lys (Alc) -oh | 6298/3/9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 106 | FMOC-Or.HCL | 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 107 | H-Ort (BOC) -Hoh | 13650-49-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 108 | FMOC-SER-Oh | 73724-45-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 109 | H-Ser (TBU) -OH | 18822-58-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 110 110 | H-Ser (TRT) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 111 111 | Fmok-oh.h2o | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 112 | H-the (tbu) -oh | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 113 | Fmok-trp-oh | 35737-15-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 114 114 | H-TRAP (BOC) -OH | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 115 115 | Fmok-d-trp-oh | 86123-11-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 116 116 | HD-TRAD (BOC) -OH | 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 117 117 | FMOC-Tir-Oh | 92954-90-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 118 | H-Tir (TBU) -OH | 18822-59-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 119 119 | FMR-D-Tir-Oh | 112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 120 | HD-Tir (vat) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 121 | H-Tir (Me) -oh.hcl | 67423-44-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 122 | FMOC-D-ISH (CBM) -O | 324017-22-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 123 | Hd-4afa (Tbucmm) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 124 | FMOC-LYS (IPR) -O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 125 | H-LYS (IPR, BOC) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
Haqida
Kompensatsiya
Gentmox juda sifatli mahsulotlar beradi, agar mahsulot sifati etarli dalillar bilan belgilangan muddat ichida katta bo'lgan bo'lsa, biz kompensatsiyalar tartibini o'zgartirish uchun zarur tahlil va baholashni ta'minlaymiz.
Ishlab chiqarish
Farmatsevtika mahsulotlarining tonna naviga yetdi, kimyoviy mahsulotlar 100 dan + gacha bo'lgan kimyoviy mahsulotlar sig'imi 100 dan + gacha, imkoniyatlar dunyo bo'ylab mijozlarga xizmat ko'rsatish imkoniyatiga ega.
Tadqiqot va ishlab chiqish
Har yili R & D jamoasi turli xil yangi mahsulotlarni ishlab chiqaradigan reja mavjud bo'lib, maqsadlar o'rnatilganda, har bir a'zo KPIning javobgarligi va rag'batlantiruvchi siyosat bilan shug'ullanishi kerak.
